Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Aug 30, 2013

NEW YORK (GenomeWeb News) – Waters said this week that Douglas Berthiaume plans to retire from his position as CEO of the company sometime in the next two years.

The company's board of directors has appointed a succession planning committee to lead the selection of a successor, and it plans to hire an executive search firm. Waters said it plans to consider candidates who are already with the company and external candidates as well.

Berthiaume was appointed president and CEO of Waters in 1994, when the business was split from Millipore, and he took on the role of chairman in 1996. During his tenure, Waters said, the company has seen a 500 percent increase in revenues and a 25-fold increase in its share price since its IPO in 1995.


Kip Miller has joined the board of directors at Solulink, the San Diego-based firm said this week. Miller most recently was president of Genetic Systems at Life Technologies. He also was senior VP of Biodiscovery at Invitrogen prior to its merger with Applied Biosystems. Miller also held various posts at BD, including VP and GM of BD Biosciences Research Cell Analysis business, VP and GM of Pharmignen, and VP of sales and service for the Americas.


Biotheranostics has added three new members to its senior management team, including Gail Sloan as CFO, Macey Johnson as VP of managed care and reimbursement, and Matt Sargent as Breast Cancer Index commercialization leader.

Sloan previously was assistant controller at Affymax Research Institute, where she helped lead the spinoff of Affymetrix, and she was CFO and VP of finance at La Jolla Pharmaceutical. Johnson formerly worked at Genomic Health, where he developed managed care messaging and strategy for molecular assays, and he worked at Genentech, where he helped launch Avastin, Herceptin, and Tarceva.

Sargent recently was VP of oncology sales for Caris Life Sciences, where he built and trained the oncology sales team, and he has held senior sales and marketing positions at Exiqon Diagnostics and MedTrust Online.


Scottish microarray maker Arrayjet said this week that Alan Faichney has joined its board as non-executive chairman. Faichney has 33 years of experience working in technology sectors, including as CEO of Edinburgh Instruments, COO of the software firm DEM-Solutions, and as senior VP of Ion Geophysical.


Applied Proteomics has appointed Genting Berhad Chairman and CEO Tan Sri Lim Kok Thay to its board of directors upon completion of a Series C funding round led by Genting Berhad.


Peter Hirth has joined KineMed's board of directors. Hirth was previously CEO of Plexxikon. Before that he was president of Sugen and vice president of research at Boehringer Mannheim.


Cecilia Lindgren, a professor at the Wellcome Trust Centre for Human Genetics, has been awarded the first Leena Peltonen Prize for Excellence in Human Genetics, which includes an award of €10,000 ($13,000).

The biennial prize was established in 2010 to recognize scientists who are in the early phases of their independent careers, and it is funded by the Leena Peltonen Memorial Fund in the Paulo Foundation.

Lindgren received the award for her work for applying genetics and genomics to understanding the etiology of type 2 diabetes, obesity, and fat distribution.


ACM Global Central Laboratory has tapped Alexander van Amerongen to be director of anatomic pathology. Amerongen, who is certified by the American Board of Pathology in anatomic pathology, clinical pathology, and cytopathology and received his doctorate from the University of South Dakota School of Medicine, will be responsible for ensuring the quality of ACM Global's pathology and cytology services


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.